Target intelligence / Profile preview

Immune system modulation via induction of tolerance to *Phleum pratense* allergens (None)

Target
None
Molecular classification
Immunomodulatory therapy, Allergen extract, Vaccine
01

Overview

Immune system modulation via induction of tolerance to allergens from *Phleum pratense* (timothy grass) is a therapeutic strategy employed in allergen-specific immunotherapy (AIT). This approach aims to reduce allergic responses by gradually training the immune system to tolerate specific allergens like Phl p 1 and Phl p 5. The therapy involves controlled exposure to allergens, leading to increased IgG4 production, decreased hypersensitivity, and expansion of regulatory T cells, ultimately downregulating allergic inflammation. AIT can prevent new sensitizations and potentially progression from rhinitis to asthma.

Other names
Allergen-specific immunotherapy (AIT) for *Phleum pratense*Timothy grass allergy immunotherapyPhl p 1 and Phl p 5 targeting immunotherapy
02

Mechanism of action

Repeated exposure to allergen leads to increased allergen-specific IgG4, decreased IgE-mediated hypersensitivity, expansion of regulatory T cells (Tregs), and altered cytokine profiles (increased IL-10 and TGF-beta).

03

Biological functions

Immune tolerance inductionRegulation of allergic responseB cell modulationT cell modulationIgG4 productionCytokine regulation
04

Disease associations

Allergic rhinitisAllergic asthmaGrass pollen allergy
05

Safety considerations

AnaphylaxisLocal injection site reactionsExacerbation of allergic symptomsRisk of new sensitizations (though less likely with purified allergens)Eosinophilic esophagitis
06

Interacting drugs

Phleum pratense allergen extract

4 more in the full profile.

07

Biomarkers

Phl p 1-specific IgE levelsPhl p 5-specific IgE levelsPhl p 1-specific IgG4 levelsPhl p 5-specific IgG4 levelsRegulatory T cell (CD4+CD25+) frequencyIL-10 productionTGF-beta productionSkin prick test reactivity to *Phleum pratense*

Beyond the preview

Go deeper on Immune system modulation via induction of tolerance to *Phleum pratense* allergens (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune system modulation via induction of tolerance to *Phleum pratense* allergens (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call